2015 PowerPoint Presentations
(A full screen PPT link can be found under the embedded PPT displays)MCI_Dickson_Neurodegenerative_tauopathies (2)
MCI 2015 Dennis Dickson – Neurodegenerative Tauopathies
MCI 2015 Dennis Dickson – Neurodegenerative Tauopathies
Josephs_MCI2015
MCI 2015 Keith Josephs – Role of TDP-43 in Non-Alzheimer’s and Alzheimer’s Neurodegenerative Diseases
MCI 2015 Keith Josephs – Role of TDP-43 in Non-Alzheimer’s and Alzheimer’s Neurodegenerative Diseases
MCKEE-MCI2
MCI 2015 Ann McKee – Emerging Concepts in Chronic Traumatic Encephalopathy
MCI 2015 Ann McKee – Emerging Concepts in Chronic Traumatic Encephalopathy
Miller MCI 2015
MCI 2015 Zachary Miller – New Approaches towards Interventions in Frontotemporal Dementia
MCI 2015 Zachary Miller – New Approaches towards Interventions in Frontotemporal Dementia
McKeith MCI 2015
MCI 2015 Ian McKeith – How to Diagnose Early (Prodromal) Lewy Body Dementia
MCI 2015 Ian McKeith – How to Diagnose Early (Prodromal) Lewy Body Dementia
Greicius Miami_MCI_2015
MCI 2015 Michael Greicius – Brain Networks in Neurodegenerative Disease
MCI 2015 Michael Greicius – Brain Networks in Neurodegenerative Disease
Rogalski_MCI2015
MCI 2015 Emily Rogalski – Clinical and Imaging Features of Prodromal PPA
MCI 2015 Emily Rogalski – Clinical and Imaging Features of Prodromal PPA
Wolk_MCI_2015a
MCI 2015 David Wolk – What is the Etiology of Amyloid Negative Mild Cognitive Impairment?
MCI 2015 David Wolk – What is the Etiology of Amyloid Negative Mild Cognitive Impairment?
Morris MCI 2015
MCI 2015 John Morris – Longitudinal Changes in Autosomal Dominant AD: Implications for Treatment
MCI 2015 John Morris – Longitudinal Changes in Autosomal Dominant AD: Implications for Treatment
Caselli MCI 2015
MCI 2015 Richard Caselli – Correlating Cognition and Biomarkers in Preclinical APOE e4 and PS1 Mutation Carriers
MCI 2015 Richard Caselli – Correlating Cognition and Biomarkers in Preclinical APOE e4 and PS1 Mutation Carriers
Vemuri_MCI2015
MCI 2015 Prashanthi Vemuri – Cross-sectional and Longitudinal Imaging studies in Non-demented Subjects: Mayo Clinic Study of Aging
MCI 2015 Prashanthi Vemuri – Cross-sectional and Longitudinal Imaging studies in Non-demented Subjects: Mayo Clinic Study of Aging
Landau_MCI2015
MCI 2015 Susan Landau – Understanding Biomarker Relationships in Alzheimer’s Disease: The ADNI Experience
MCI 2015 Susan Landau – Understanding Biomarker Relationships in Alzheimer’s Disease: The ADNI Experience
Rowe_MCI2015a
MCI2015 Christopher Rowe – Cross-sectional and Longitudinal Studies in LOAD: AIBL Experience
MCI2015 Christopher Rowe – Cross-sectional and Longitudinal Studies in LOAD: AIBL Experience
Wilson MCI 2015
MCI 2015 Robert Wilson – Personality, Lifestyle, and Cognitive Health in Old Age
MCI 2015 Robert Wilson – Personality, Lifestyle, and Cognitive Health in Old Age
Woods MCI 2015
MCI 2015 Robert Woods – Cognitive Engagement and Risk for MCI and Dementia
MCI 2015 Robert Woods – Cognitive Engagement and Risk for MCI and Dementia
Kawas_MCI2015a
MCI 2015 Claudia Kawas – Risk Factors for Dementia in the Oldest Old
MCI 2015 Claudia Kawas – Risk Factors for Dementia in the Oldest Old
Kirk-Sanchez MCI symposium
MCI 2015 Neva Kirk Sanchez – How Does Exercise Benefit People at Risk for Dementia?
MCI 2015 Neva Kirk Sanchez – How Does Exercise Benefit People at Risk for Dementia?
Black MCI 2015
MCI 2015 Sandra Black – Vascular Factors which Modify Risk for Dementia
MCI 2015 Sandra Black – Vascular Factors which Modify Risk for Dementia
Golde MCI 011715 final
MCI 2015 Todd Golde – Assessing the Current Roadmap for Developing Novel Disease Modifying Therapies for Neurodegenerative Diseases
MCI 2015 Todd Golde – Assessing the Current Roadmap for Developing Novel Disease Modifying Therapies for Neurodegenerative Diseases
dickerson_mci_jan2015 (1)
MCI 2015 Brad Dickerson – CI of the FLTD type: Clinical Features and Imaging and Molecular Biomarkers
MCI 2015 Brad Dickerson – CI of the FLTD type: Clinical Features and Imaging and Molecular Biomarkers